CH587801A5 - - Google Patents

Info

Publication number
CH587801A5
CH587801A5 CH151874A CH151874A CH587801A5 CH 587801 A5 CH587801 A5 CH 587801A5 CH 151874 A CH151874 A CH 151874A CH 151874 A CH151874 A CH 151874A CH 587801 A5 CH587801 A5 CH 587801A5
Authority
CH
Switzerland
Application number
CH151874A
Original Assignee
Christiaens Sa A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Christiaens Sa A filed Critical Christiaens Sa A
Publication of CH587801A5 publication Critical patent/CH587801A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH151874A 1973-02-05 1974-02-04 CH587801A5 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB563173A GB1462036A (en) 1973-02-05 1973-02-05 Aminoindane derivatives
GB1030273 1973-03-02

Publications (1)

Publication Number Publication Date
CH587801A5 true CH587801A5 (xx) 1977-05-13

Family

ID=26240034

Family Applications (1)

Application Number Title Priority Date Filing Date
CH151874A CH587801A5 (xx) 1973-02-05 1974-02-04

Country Status (15)

Country Link
US (1) US3923887A (xx)
JP (1) JPS5327264B2 (xx)
AR (1) AR201218A1 (xx)
CA (1) CA1022172A (xx)
CH (1) CH587801A5 (xx)
DD (2) DD114906A5 (xx)
DE (1) DE2405094A1 (xx)
ES (1) ES422906A1 (xx)
FR (1) FR2215958B1 (xx)
GB (1) GB1462036A (xx)
HU (1) HU169033B (xx)
IL (1) IL44086A (xx)
LU (1) LU69308A1 (xx)
NL (1) NL7401501A (xx)
YU (1) YU36010B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018897A (en) * 1974-07-03 1977-04-19 Eli Lilly And Company Antiarrhythmic agents
US3987201A (en) * 1974-12-24 1976-10-19 Eli Lilly And Company Method for treating arrhythmia
US4192883A (en) * 1976-04-09 1980-03-11 Pierre Fabre, S.A. Amides of pyrrolidinoethylamine which can be used in lung therapy
EP0035868A1 (en) * 1980-03-07 1981-09-16 Takeda Chemical Industries, Ltd. Bicyclic compounds, their production and use
US4873241A (en) * 1988-10-31 1989-10-10 Fisons Corporation 2-amino-N-(2-phenylindan-2-yl)acetamides useful as anti-epileptics
EP1658847A3 (en) * 1999-06-10 2006-07-26 Bridge Pharma, Inc. Indane derivatives as dermal anesthetic agents
ATE335482T1 (de) 1999-06-10 2006-09-15 Bridge Pharma Inc Dermale anästhetika
US7718674B2 (en) * 2004-09-27 2010-05-18 Bridge Pharma, Inc. Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
WO2006037047A2 (en) * 2004-09-27 2006-04-06 Bridge Pharma, Inc. The r-isomer of 2-{2-[n-(2-indanyl)-n-phenylamino]ethyl}piperidine and other dermal anesthetic agents
CA2655809C (en) * 2006-07-21 2013-10-01 Bridge Pharma, Inc. Dermal anesthetic compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2948736A (en) * 1957-08-05 1960-08-09 Cilag Chemie New anilides and process for their production
BE667486A (xx) * 1964-07-27

Also Published As

Publication number Publication date
NL7401501A (xx) 1974-08-07
IL44086A (en) 1976-11-30
US3923887A (en) 1975-12-02
JPS5327264B2 (xx) 1978-08-07
AR201218A1 (es) 1975-02-21
YU23474A (en) 1981-04-30
AU6508874A (en) 1975-08-07
DD114906A5 (xx) 1975-09-05
YU36010B (en) 1981-11-13
JPS49102659A (xx) 1974-09-27
LU69308A1 (xx) 1974-05-29
HU169033B (xx) 1976-09-28
GB1462036A (en) 1977-01-19
DD112989A5 (xx) 1975-05-12
IL44086A0 (en) 1974-05-16
ES422906A1 (es) 1976-05-01
DE2405094A1 (de) 1974-08-08
FR2215958A1 (xx) 1974-08-30
CA1022172A (en) 1977-12-06
FR2215958B1 (xx) 1978-01-06

Similar Documents

Publication Publication Date Title
FR2215958B1 (xx)
AU477823B2 (xx)
AR195948A1 (xx)
AU477824B2 (xx)
AR195311A1 (xx)
AR193950A1 (xx)
BG21603A3 (xx)
BG19337A1 (xx)
CH564368A5 (xx)
CH565994A5 (xx)
CH593909A5 (xx)
CH564335A5 (xx)
CH563937A5 (xx)
CH562068A5 (xx)
CH561920A5 (xx)
CH566774A4 (xx)
BG21583A3 (xx)
CH567129A5 (xx)
BG20891A1 (xx)
BG20875A1 (xx)
BG19515A1 (xx)
BG19070A1 (xx)
BG18953A1 (xx)
BG18723A1 (xx)
AU479562A (xx)

Legal Events

Date Code Title Description
PL Patent ceased